TriSalus Life Sciences, Inc.
TLSI
$5.22
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.84% | -3.15% | -34.89% | -25.53% | -46.38% |
| Total Depreciation and Amortization | 72.71% | 64.08% | 126.71% | 73.87% | -28.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 517.77% | -50.80% | 16.06% | -36.92% | -2,102.56% |
| Change in Net Operating Assets | -25,266.67% | -218.59% | -82.60% | -73.48% | -95.79% |
| Cash from Operations | 11.52% | -64.24% | -57.06% | -55.51% | -74.49% |
| Capital Expenditure | -58.81% | -130.72% | -65.05% | 10.23% | 57.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,088.24% | -48.86% | -278.26% | -150.38% | 22.73% |
| Cash from Investing | 33.13% | -31.93% | -30.60% | -7.28% | 27.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 54.69% | 49.12% | 42.76% | 33.59% | 57.99% |
| Issuance of Common Stock | 10,930.43% | 7,206.38% | 3,848.19% | 90.43% | 7.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -81.45% | -48.99% | 39.41% | 106.79% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -107.31% | -- | -- | -- | -- |
| Cash from Financing | -42.17% | 186.45% | 133.57% | 305.80% | 418.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.53% | 219.57% | 78.17% | 111.93% | 149.19% |
